Sanofi launches multiple sclerosis treatment drug in India
Aubagio offers patients the efficacy and convenience of once-a-day oral treatment06-08-2018
06-08-2018
India is a must-win country for us, will invest in new products: Sanofi MD
The company is not only working on bringing in new global drugs but is also keen on ramping up exports from the country05-08-2018
Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find enclosed copies of the Notice of Record Date of the Company published today,in newspapers, Business Standard and Sakal.27-07-2018
Fixes Record Date for Interim Dividend
Sanofi India Ltd has informed BSE that the Company has fixed August 07, 2018 as the Record Date for the purpose of Payment of Interim Dividend.The said dividend will be paid on or after August 14, 2018.26-07-2018
Announcement under Regulation 30 (LODR)-Resignation of Director
We would like to inform you that Mr. Lionel Guerin has informed the Company that he would be relocating outside of India to take up a new role within Sanofi Group and hence would like to resign as Non-Executive Director with effect from the end of the business hours on 25th July 2018. The Board took note of this resignation today and placed on record its appreciation for the contribution made by Mr. Lionel Guerin during his tenure as Director of the Company.25-07-2018
Announcement under Regulation 30 (LODR)-Change in Directorate
The Board of Directors of the Company at its Meeting held today approved the appointment of Mr. Charles Billard, Chief Financial Officer (DIN 08173583) as Additional Director to hold the office up to the next Annual General Meeting of the Company. The Board also approved appointment of Mr. Charles Billard as Whole time Director for a period of 5 years with effect from 25th July 2018 subject to approval of the Central Government and the members of the Company....25-07-2018
Corporate Action-Board approves Dividend
The Board of Directors of the Company at its Meeting held today has declared an Interim Dividend of Rs. 18 per equity share of Rs. 10 each for the financial year ending 31st December 2018. The Meeting of Board of Directors commenced at 2.30 p.m. and concluded at 5.20 p.m. The Company has fixed 7th August 2018 as the record date for the purpose of payment of the Interim Dividend. The said dividend will be paid on or after 14th August 2018.25-07-2018
Results- Financial Results For Jun 30,2018
We refer to our letter dated 17th July 2018 informing you of our Board Meeting that was scheduled today. The Meeting of Board of Directors commenced at 2.30 p.m. and concluded at 5.20 p.m. The Board approved unaudited financial results for the quarter and half year ended 30th June 2018. We enclose a copy of the unaudited financial results of the quarter and half year ended 30th June 2018 approved at this Meeting and the Limited Review Report...25-07-2018
Results- Financial Results For Jun 30,2018
We refer to our letter dated 17th July 2018 informing you of our Board Meeting that was scheduled today. The Meeting of Board of Directors commenced at 2.30 p.m. and concluded at 5.20 p.m. The Board approved unaudited financial results for the quarter and half year ended 30th June 2018. We enclose a copy of the unaudited financial results of the quarter and half year ended 30th June 2018 approved at this Meeting and the Limited Review Report...25-07-2018
Corporate Action-Board to consider Dividend
We refer to our earlier letter dated 17th July 2018 informing about Company''s Board meeting to be held on 25th July 2018 for approval of financial results for the quarter and half year ended 30th June 2018 (Q2). Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would also like to inform you that the Board will also consider declaration of Interim Dividend for the year ending 31st December 2018 at the same meeting.19-07-2018